Altered lysophospholipid profiles in plasma and skeletal muscle in type 2 diabetes: sex-specific metabolic signatures

Abstract Aims Type 2 diabetes is characterised by aberrant glucose metabolism and additional metabolic changes. This study explores plasma and skeletal muscle metabolite response during transition from fasting to fed following a glucose challenge in individuals with or without type 2 diabetes. Methods Mass spectrometry-based metabolomics was performed on skeletal muscle and plasma samples collected under fasting and 2 h into an OGTT from BMI, age, and sex-matched individuals, with either normal glucose tolerance ( N = 42) or type 2 diabetes ( N = 45). Skeletal muscle transcriptome was assessed using an expression array. Links between differentially abundant transcripts and metabolites were investigated using siRNA-mediated gene silencing in cultured human skeletal muscle cells. Results Lysophospholipids were the predominant metabolite class in skeletal muscle and plasma discriminating between people with normal glucose tolerance or type 2 diabetes, before and after the glucose challenge. Sex-specific differences in the lysophospholipid response were noted in skeletal muscle, but not plasma. Transcriptomic analysis revealed several genes with altered fasting-state expression in skeletal muscle in a disease-specific manner ( ABCG1 , BDH1 and PCYT2 ). Silencing experiments in cultured muscle identified ABCG1 and BDH1 as modulators of lysophospholipid abundance in cultured human myotubes, with ABCG1 showing sex-dependent effects. Conclusions This research identifies metabolic signatures of type 2 diabetes, emphasising the discriminatory role of lysophospholipids in skeletal muscle and plasma. The link between ABCG1 expression and lysophospholipid content may be influenced by biological sex, highlighting the need to explore sex-specific differences in metabolic regulation in type 2 diabetes.

Authors

Publication Details

Journal
Metabologia
Published
2026-11-14
DOI
https://doi.org/10.1007/s44357-026-00027-1
Primary Topic
Metabolomics and Mass Spectrometry Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Altered lysophospholipid profiles in plasma and skeletal muscle in type 2 diabetes: sex-specific metabolic signatures

Juleen Rae Zierath, Marie Björnholm, Thomas Moritz, Alexander Chibalin et al.
Metabologia
Metabolomics and Mass Spectrometry Studies
article

Altered lysophospholipid profiles in plasma and skeletal muscle in type 2 diabetes: sex-specific metabolic signatures

Juleen Rae Zierath, Marie Björnholm, Thomas Moritz, Alexander Chibalin, Duarte M. S. Ferreira, Anna Krook, Natalie J. Norman, Elin Chorell, Håkan Karlsson, Hui Gao, Erik Näslund, Mutsumi Katayama
article en

Abstract

Abstract Aims Type 2 diabetes is characterised by aberrant glucose metabolism and additional metabolic changes. This study explores plasma and skeletal muscle metabolite response during transition from fasting to fed following a glucose challenge in individuals with or without type 2 diabetes. Methods Mass spectrometry-based metabolomics was performed on skeletal muscle and plasma samples collected under fasting and 2 h into an OGTT from BMI, age, and sex-matched individuals, with either normal glucose tolerance ( N = 42) or type 2 diabetes ( N = 45). Skeletal muscle transcriptome was assessed using an expression array. Links between differentially abundant transcripts and metabolites were investigated using siRNA-mediated gene silencing in cultured human skeletal muscle cells. Results Lysophospholipids were the predominant metabolite class in skeletal muscle and plasma discriminating between people with normal glucose tolerance or type 2 diabetes, before and after the glucose challenge. Sex-specific differences in the lysophospholipid response were noted in skeletal muscle, but not plasma. Transcriptomic analysis revealed several genes with altered fasting-state expression in skeletal muscle in a disease-specific manner ( ABCG1 , BDH1 and PCYT2 ). Silencing experiments in cultured muscle identified ABCG1 and BDH1 as modulators of lysophospholipid abundance in cultured human myotubes, with ABCG1 showing sex-dependent effects. Conclusions This research identifies metabolic signatures of type 2 diabetes, emphasising the discriminatory role of lysophospholipids in skeletal muscle and plasma. The link between ABCG1 expression and lysophospholipid content may be influenced by biological sex, highlighting the need to explore sex-specific differences in metabolic regulation in type 2 diabetes.

MetabologiaVol. 2(1)
Metabolomics and Mass Spectrometry Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon